North Bethesda, MD — May 6, 2015 — Media Alert
In their presentation, titled “Vaccine Market Outlook / Next Billion Dollar Vaccine,” L.E.K. Consulting Managing Directors Jon Piper and Ian Tzeng will discuss the multi-billion dollar opportunity in vaccines and the evolving nature of competitive advantage. With a robust outlook for strong growth and innovation, they will explain how the Mid-Atlantic region is contributing to this advancement in vaccines, technology and health.
Friday, May 8, 2015
Bethesda North Marriott Hotel & Conference Center
5701 Marinelli Road, North Bethesda, MD
8:30 – 9:30 AM
About Jon Piper and Ian Tzeng:
Jon Piper is a Managing Director and Partner, as well as the head of L.E.K. Consulting’s Boston office and a member of L.E.K.'s Americas Regional Management Committee. He joined the firm in 1998 and has more than 20 years of consulting experience across the healthcare industry. Jon has extensive transaction, commercialization and portfolio optimization experience within the life sciences sector, working with clients at various stages of development. Within healthcare services, he has advised his clients on how best to achieve profitable growth, manage their costs and complete value creating transactions. Prior to L.E.K., Jon was a consultant with Accenture (formerly Andersen Consulting), where he focused on healthcare services. He earned his Master of Business Administration from Harvard Business School and his Bachelor of Arts in Economics from Trinity College.
Ian Tzeng, a Managing Director and Partner in L.E.K. Consulting's Boston office, has more than 17 years of consulting experience in growth strategy, regulated markets, innovation, pricing, and mergers and acquisitions. He directs projects in our Biopharmaceuticals & Life Sciences and MedTech practices, with emphasis in pricing & market access, orphan / rare diseases, and pharma services, among others. Additionally, Ian has extensive consulting and board experience with non-profit organizations in education, arts, advocacy, and public service. He received a Bachelor of Arts degree, magna cum laude, in Chemistry from Harvard College and is a George F. Baker Scholar, Master of Business Administration with high distinction from Harvard Business School.
About L.E.K. Consulting:
L.E.K. Consulting is a global management consulting firm that uses deep industry expertise and analytical rigor to help clients solve their most critical business problems. Founded more than 30 years ago, L.E.K. employs more than 1,000 professionals in 21 offices across Europe, the Americas and Asia-Pacific. L.E.K. advises and supports global companies that are leaders in their industries – including the largest private and public sector organizations, private equity firms and emerging entrepreneurial businesses. L.E.K. helps business leaders consistently make better decisions, deliver improved business performance and create greater shareholder returns.
About The Atlantic Vaccines and Immunotherapeutics Summit:
The Atlantic Vaccines and Immunotherapeutics Summit is the premier event to showcase Maryland’s global leadership role as the epicenter of vaccine innovation and development. The conference will give attendees a change to interact, learn and engage with the industry’s foremost researchers and business leaders, while tackling the pressing issues that face the new generation of vaccines.